Status:
UNKNOWN
Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Breast cancer can metastasize to the bones, which leads to another treatment if bone metastases are detected. The purpose of the study is to determine, if fluoride PET/CT is superior to bone scintigra...
Eligibility Criteria
Inclusion
- histologically proven c. mammae
- clinically suspicion of bone metastases
Exclusion
- age under 18 years
- diabetes mellitus
- pregnancy
- other known malignant disease
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2013
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01224873
Start Date
October 1 2010
End Date
September 1 2013
Last Update
January 11 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dep. of Nuclear Medicine & PET, Rigshospitalet
Copenhagen, Denmark, 2100